HBHumain Baharvahdat

Humain Baharvahdat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Humain Baharvahdat has a total of 323 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predictors of Hemorrhagic Transformation After IV Continuous Cangrelor Infusion Initiated During Mechanical Thrombectomy

    by Andrea Gambino, David Weisenburger-Lile, Aurélien Freiherr von Seckendorff, Manar Abomulay, Marie Ernst, Benjamin Maïer, Pierre Seners, Michel Piotin, Raphaël Blanc, Simon Escalard, et al.

    BACKGROUND: Cangrelor, a fast-acting intravenous P2Y12 receptor inhibitor, is increasingly used during mechanical thrombectomy for acute ischemic stroke to treat or prevent thrombotic complications. While effective, its use may increase the risk of hemorrhagic transformation (HT). We investigated clinical, imaging, and procedural predictors of HT in this specific patient population. METHODS: We performed a retrospective post hoc single-center study including 101 patients with acute ischemic stroke treated with intravenous cangrelor initiated directly after mechanical thrombectomy and continued for 12 hours between January 2021 and June 2024. Univariate and multivariable logistic regression models were used to assess associations between HT and clinical, radiological, and procedural factors. RESULTS: Among the 101 patients included, 25 (24.7%) developed HT, and 9 (8.9%) experienced symptomatic intracerebral hemorrhage. In multivariable analysis, baseline blood glucose (adjusted odds ratio, 6.51 [95% CI, 1.35–31.4]; P =0.02), leukocytosis (adjusted odds ratio, 1.18 [95% CI, 1.00–1.38]; P =0.047), and subarachnoid hemorrhage on postmechanical thrombectomy cone-beam computed tomography (adjusted odds ratio, 16.60 [95% CI, 2.97–92.8]; P =0.0014) were independent predictors of HT. Contrast enhancement was associated with HT in univariate analysis but did not remain significant after adjustment. CONCLUSIONS: Baseline blood glucose, leukocytosis, and isolated subarachnoid hemorrhage on postmechanical thrombectomy cone-beam computed tomography emerged as independent predictors of HT. Identifying high-risk patients using readily available clinical and imaging markers may support individualized antiplatelet strategies and help reduce hemorrhagic complications during cangrelor treatment. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03776877.

  • Customized 3D-printed Poly ether ether ketone cranial implant for cranioplasty of skull defects

    by Farid Qoorchi Moheb Seraj, Daniel Kheradmand, Sajjad Najafi, Masoumeh Jahed Taghi Dizaj, Sanaz Salmasian, Arash Ghasemi, Reza Ghasemi, Samira Zabihyan, Hamid Etemadrezaie, Feizollah Ebrahimnia, et al.

    Cranioplasty become one of the common surgeries in the neurosurgical field. The complex configuration of the cranium makes the bone reconstruction of the skull defects a challenging procedure. While the patient’s own bone flap is the best option, other materials such as titanium and Poly ether ether Ketone (PEEK) were used for cranioplasty when the autogenous flap of the patient is unavailable. Recently, customized 3D printing implants were developed for cranioplasty with favorable outcomes. In this study, we evaluated the outcome of customized 3-dimentional (3D)-printed PEEK implant cranioplasty for reconstructing skull defects, especially large ones. We report a series of 27 patients whose skull defects were reconstructed by a customized 3D-printed PEEK implants. Demographic data and postoperative clinical and imaging findings were reviewed. We analyzed the complications, clinical and aesthetic outcomes during mid-term follow-up. During the surgery, all the implants were perfectly fitted in the skull defect without any major modification. Aesthetic results were satisfactory in 74.1% of patients. 4 patients (14.8%) had complications, including 3 deep cranial infections (11.1%) and one extradural hematoma (3,7%). In 2 patients (7.4%), the implants were removed due to infection. Therefore, when autologous bone is unavailable or, in selected cases with large or complex skull defects, customized 3D-printed PEEK implants could be a proper option to reconstruct these defects.


  • Open Access

    Curative Treatment of Brain Arteriovenous Malformations Combining Endovascular and Surgical Approaches Consecutively

    by Ran Brauner, Stanislas Smajda, Dorian Chauvet, Sorin Aldea, Simon Escalard, Jean-Philippe Désilles, Hocine Redjem, Amira Al Raaisi, Humain Baharvahdat, William Boisseau, et al.


  • Open Access

    Treatment of Traumatic Direct Carotid-Cavernous Fistula with a BeGraft-Covered Stent

    by Farid Qoorchi Moheb Seraj, Sajjad Najafi, Amira Al Raaisi, Mohammad Hossein Mirbolouk, Feizollah Ebrahimnia, Hashem Pahlavan Shamsi, Yousef Garivani, Samira Zabihyan, Ashkan Mowla, Humain Baharvahdat

    The widely accepted option for treating traumatic direct carotid-cavernous fistula (dCCF) has been endovascular treatment using detachable balloons, coils, or embolic agents. Covered stent deployment has been applied by a few operators and has shown promising results. This is a retrospective study on patients with dCCF treated by an endovascular approach using BeGraft, a covered stent. In 4 cases, this device was successfully deployed without any complications. Immediate complete occlusion was achieved in 3 patients (75%) after deployment of the covered stents. One patient required transvenous coiling for occlusion of the remaining endoleak. Follow-up imaging demonstrated 100% fistula occlusion with complete internal carotid artery patency. No early or late complications occurred following treatment. In conclusion, the BeGraft-covered stent could be a promising safe and effective alternative option for the endovascular treatment of dCCF.


  • Low-Profile Visualized Intraluminal Support Device for Y-Stent-Assisted Coiling of Wide-Neck Intracranial Aneurysms: A Single-Center Experience

    by Sajjad Saghebdoust, Farid Qoorchi Moheb Seraj, Sajjad Najafi, Daniel Kheradmand, Mohammad Hossein Mirbolouk, Ashkan Mowla, Hashem Pahlavan, Ali Sadeghian, Ali Mortezaei, Mahla Esmaeilzadeh, et al.

  • Open Access

    Coil entrapment in temporary stent-assisted coiling of wide-neck aneurysm: a case report

    by Farid Qoorchi Moheb Seraj, Feizollah Ebrahimnia, Sajjad Najafi, Mahla Esmaeilzadeh, Humain Baharvahdat

    Background: Endovascular treatment of the wide-necked aneurysm is still challenging. Temporary stent-assisted coiling (TSAC) was introduced to manage the ruptured wide-necked aneurysms to avoid the long-term use of dual antiplatelets as well as improving aneurysm filling with coils. Case presentation: Here, we reported a case of the coil entrapment into the stent device during TSAC for the treatment of a wide-necked large ruptured aneurysm. Patient presented with loss of consciousness following diffuse subarachnoid hemorrhage due to a wide-necked large aneurysm located in the left ICA bifurcation. During treatment of aneurysm with TSAC technique, the stent could not retrieve and re-sheath because of coil entrapment in the stent struts. Consequently, the stent was released by cutting the pushing wire at the puncture site. Conclusion: Entrapment of coils in the stent struts is a very rare technical complication of TSAC method. It is essential to be aware of this side effect and how to avoid.

  • Open Access

    Long-term outcome of endovascular treatment for indirect carotid-cavernous fistulas

    by Humain Baharvahdat, Farid Qoorchi Moheb Seraj, Amira Al-Raaisi, Raphael Blanc, Sajjad Najafi, Mohammad Hossein Mirbolouk, Hocine Redjem, Feizollah Ebrahimnia, Simon Escalard, Samira Zabihyan, et al.

    OBJECTIVE: Endovascular treatment (EVT) is the primary approach used to treat indirect carotid-cavernous fistulas (CCFs). In this study, the authors evaluated the immediate and long-term efficacy and safety of different endovascular techniques for indirect CCFs. METHODS: The databases of two endovascular centers were retrospectively reviewed to collect the patients with indirect CCFs treated using endovascular techniques between 2013 and 2023. Demographics, clinical presentation, CCF features, EVT characteristics, and clinical and radiological outcomes were evaluated and analyzed. The analysis was performed to compare the clinical and radiological data between different endovascular approaches and different embolic materials. RESULTS: Ninety-eight patients were included in the study. EVT was successful in 95 patients (96.9%). Immediate complete obliteration of the CCF was achieved in 93.9% of patients, with 98% undergoing embolization with liquid embolic agents (LEAs) and 95.6% undergoing coiling alone. Complete CCF obliteration was higher in the transvenous than in the transarterial approach (94.3% vs 75%, p = 0.010). At ≥ 6 months follow-up, complete CCF obliteration was achieved in all patients (100%). The rate of procedure-related complications was higher following LEAs than with coiling alone (32.0% vs 15.6%). New cranial nerve (CN) palsy was diagnosed in 26.0% and 2.2% after embolization with LEAs and coiling alone, respectively (p = 0.001), with complete CN palsy recovery in 78.6%. Procedure-related intracranial hemorrhage occurred in 3 patients (3.1%). Two patients experienced an ischemic stroke following Onyx migration into the internal carotid artery. Ocular symptoms improved in 93% (83/89) of the patients who were followed. CONCLUSIONS: In this study, complete obliteration of an indirect CCF was achieved in more than 90% of patients. Despite the occurrence of some new postprocedural ocular CN palsy, ocular symptoms improved in most patients in long-term follow-up. The transvenous approach was the most effective method for treating the indirect CCF. Coiling was safer than LEAs for the embolization of the indirect CCF.


  • Open Access

    Unilateral Oculomotor Nerve Palsy as a Rare Manifestation of Isolated Pre-Communicating Segment of Posterior Cerebral Artery Thrombosis

    by Farid Qoorchi Moheb Seraj, Sajjad Najafi, Hashem Pahlavan, Hossein Organji, Humain Baharvahdat

    Ipsilateral mydriasis (IM) is usually not acute. However, the acute occurrence of unilateral dilated pupil may result in acute ischemic stroke. Herein, we present 3 patients with IM, lateral eye deviation, ptosis, and contralateral hemiparesis due to isolated occlusion of the pre-communicating segment of the posterior cerebral artery with preservation of the posterior communicating artery, which was successfully treated by emergent mechanical thrombectomy. In a 3-month follow-up, all patients were independent without any neurological deficits.

  • Open Access

    Safety of dual antiplatelet therapy in the acute phase of aneurysmal subarachnoid hemorrhage: a propensity score–matched study

    by Farid Qoorchi Moheb Seraj, Mohammad Hossein Mirbolouk, Marjan Vaezi, Feizollah Ebrahimnia, Reza Gorji, Sajjad Najafi, Hashem Pahlavan Shamsi, Ali Sadeghian Shahi, Payam Sasannejad, Samira Zabihyan, et al.

    OBJECTIVE: With the evolution of neuroendovascular treatments, there is a great trend to treat acutely ruptured wide-necked aneurysms with stent-assisted coiling (SAC) and flow diverters (FDs), which inevitably requires dual antiplatelet therapy (DAPT). This therapy can increase the rate of hemorrhagic complications following other neurosurgical maneuvers, such as external ventricular drain (EVD) placement or removal. In this study, the authors aimed to evaluate the safety of DAPT in patients with aneurysmal subarachnoid hemorrhage (SAH) treated with SAC or FDs and the therapy’s potential benefit in reducing cerebral ischemia and cerebral vasospasm. METHODS: In this retrospective study, the authors reviewed the records of patients who had been admitted to their hospital with acute aneurysmal SAH and treated with SAC, FDs, and/or coiling between 2012 and 2022. Patients were classified into two groups: a DAPT group, including patients who had received DAPT for SAC or FDs, and a non-DAPT group, including patients who had not received any antiplatelet regimen and had been treated with coiling. Perioperative hemorrhagic and ischemic complications and clinical outcomes were compared between the two groups. RESULTS: From among 938 cases of acute ruptured aneurysms treated during 10 years of study, 192 patients were included in this analysis, with 96 patients in each treatment group, after propensity score matching. All basic clinical and imaging characteristics were equivalent between the two groups except for the neck size of aneurysms (p < 0.001). EVD-related hemorrhage was significantly higher in the DAPT group than in the non-DAPT group (p = 0.035). In most patients, however, the EVD-related hemorrhage was insignificant. Parent artery or stent-induced thrombosis was higher in the DAPT group than in the non-DAPT group (p = 0.003). The rate of cerebral ischemia was slightly lower in the DAPT group than in the non-DAPT group (11.5% vs 15.6%, p = 0.399). In the multivariate analysis, cerebral ischemia, rebleeding before securing the aneurysm, extracranial hemorrhage, and cerebral vasospasm were the predictive factors of a poor clinical outcome (p < 0.001, p < 0.001, p = 0.038, and p = 0.038, respectively). CONCLUSIONS: The DAPT regimen may be safe in the setting of acute aneurysmal SAH. Although EVD-related hemorrhage is more common in the DAPT group than the non-DAPT group, it is usually insignificant without any neurological deficit.


  • Open Access

    E-274 Endovascular management of high-grade cerebral arteriovenous malformation

    by H Baharvahdat, R Blanc, S Escalard, J Desilles, H Redjem, F Delvoye, S Smajda, A Al Raaisi, W Boisseau, M Mazighi, et al.

    Introduction High grade cerebral AVM (Spetzler grade 4 and 5) have a very complex structure and architecture. Accordingly, their management is very challenging. Their natural history also is known to be poor. We present our experience of patients with high-grade cerebral AVM and their management with endovascular methods. Methods Sixty-seven patients with high-grade cerebral AVM with one embolization session between 2010 and 2021 were included in this study. The baseline and treatment outcomes were collected and reported. Results The mean age of patients was 29.2 years ± 15.8 (SD) with predominant of men (63.6%). The most common presentations were hemorrhage (57.6%), seizure (18.2%), and focal neurological deficit (13.6%). At patient admission, median range of modified Rankin scale was 1 (range of 0 to 4). The majority of AVMs were located in cortical and subcortical area (47%), 53 were grade 4 of Spetzler- Martin, and 14 grade 5. Mean nidus diameter was 47.8 mm ± 14.2 (SD). Median number of embolization sessions was 3 with range of 1-13. Eighteen AVMs (26.9%) were completely excluded by embolization (33% in grade 4 and 7% in grade 5). Significant complications occurred in 24 (36%) patients including hemorrhage (66.7%) and ischemia (33.3%). Fifty patients (75.8%) had good outcome (mRs 0-2) and one patient died following embolization. Conclusion Despite relative high rate of complications, the majority of our patients had good outcome that is better than natural history of the high grade cerebral AVMs. Complete exclusion of high-grade cerebral AVM could be achieved by embolization in limited patients. Further studies are needed to define the optimal management for these complex AVMs. Disclosures H. Baharvahdat: None. R. Blanc: None. S. Escalard: None. J. Desilles: None. H. Redjem: None. F. Delvoye: None. S. Smajda: None. A. Al Raaisi: None. W. Boisseau: None. M. Mazighi: None. M. Piotin: None.